Seth Eisenberg – Exposure to cytotoxic chemotherapy can result in acute and chronic conditions including nausea, headaches, rashes, miscarriages, infertility and genetic aberrations…
WHAT IS CYTOPREVENT?
A group of International Experts dedicated to changing practices to reduce potential contamination risks from occupational exposure to hazardous drugs on healthcare professionals.
Follow CytoPrevent on Twitter!
WHAT’S NEW ON CYTOPREVENT?
On 9 December 2021, Parliament’s Special Committee on Beating Cancer adopted its final proposals on how to strengthen the EU’s role in the fight against cancer. They include the following…
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work
Press Release - 16 December 2021 The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and...
Background The toxic effects of antineoplastic drugs used for cancer treatment have been well known since their introduction in the 1940s. However, beyond the patient safety concerns arising from the necessary therapeutic use of these drugs, the occupational risks to...
The Council presidency and the European Parliament have reached a provisional deal to update the carcinogens and mutagens directive, an EU law to protect workers from risks related to exposure to carcinogenic and mutagenic substances.
What is a CSTD? Does USP 800 require the use of CSTD’s for compounding HD’s? Does USP 800 require the use of CSTD’s for administering HD’s? Why do nurses need to use a CSTD when administering chemo?
Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion
Pesqué Raphaëlle, Peyrilles Elodie, Jourdan Nathalie, Albert Odile, Sessink Paul, Madelaine Isabelle, Levert Hélène.
Occupational exposure to cytotoxic drugs can lead to significant health problems. This study was designed to evaluate the risk of 5-fluorouracil (5-FU) contamination for nurses when disconnecting the infusion line of an elastomeric pump from a non-coring needle, by comparing three configurations.
The handling of Hazardous medical drugs in a cancer treatment unit requires a specific approach in order to avoid unnecessary risks for the healthcare staff, and more particularly for the nurses. The measures to be taken concern both the preparation and administration phases.
Stop Cancer at Work Campaign calls on European Commission to approve legislation now to protect workers and patients from getting cancer
The trilogue process with the European Council, Parliament and Commission under the Portuguese Presidency concludes today and there has been no discussion at all on the important legislative changes to the Carcinogens and Mutagens Directive (CMD), passed by the European Parliament to protect workers from cancer and reproductive problems at work.